An increase in seroprevalence and vaccinated individuals was observed during the study period of 2020 and 2021 . The testing algorithms were applied to two serosurveys JHH ED 2020 and JHH ED 2021.

The algorithm, which is run as part of Tempus’ xR CAP/CLIA Laboratory Developed Test, uses RNA data to predict IHC/ISH positivity in a tumor sample. Tempus is initially deploying the program at ...